
About Veriphi
Veriphi is a Healthcare company based in Auckland (New Zealand) founded in 2015 by Gregory Joseph Shanahan. Laser verification system to prevent injuries and death caused by IV systems. Veriphi has raised $736.71 thousand across 3 funding rounds from investors including Callaghan Innovation and Snowball Effect. Veriphi offers products and services including Veriphi Flushing Analyser. Its focus areas include Life Sciences, Hospital Equipment, Critical Care and Infusion Systems. Its legal entity is Veriphi Limited.
Company details
Veriphi was founded in 2015 in Auckland, New Zealand, within the health technology sector. Laser-based analyzers and IV consumables are produced to verify drug identity and concentration, reducing errors in hospital intravenous administration. Proof-of-concept trials were completed by October 2017, with commercial versions now under development for hospital trials involving 15 oncology drugs at Auckland Hospital Pharmacy.
- Headquarters Auckland, New Zealand
- Founders Gregory Joseph Shanahan
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website veriphi.co.nz
- Social LinkedIn X
- Legal Name Veriphi Limited
- Total Equity Funding$736.71K (USD)
in 3 rounds
- Latest Funding Round$372K (USD), Grant
Jan 2017
- InvestorsCallaghan Innovation
& 1 more
Products & Services of Veriphi
Veriphi offers a comprehensive portfolio of products and services, including Veriphi Flushing Analyser.
Uses lasers to verify identity and concentration of intravenous drugs.
Funding Insights of Veriphi
Veriphi has successfully raised a total of $736.71K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $372 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $736,713
- Total Rounds 3
- Last Round Grant β $372,000
- First Round $495,713
(May 2016)
- Investors Count 2
All 3 funding rounds of Veriphi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $372,000 | Grant | β | β | |
| Nov 2016 | $241,000 | Seed | β | Snowball Effect | β |
| May 2016 | $495,713 | Seed | β | Snowball Effect | β |
2 investors in total: 2 institutional.
Investors in Veriphi
Veriphi has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Callaghan Innovation and Snowball Effect.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government programs access and business development services are provided. | 2013 | callaghaninnovation.govt.nz | Parnell, United States | |
Equity crowdfunding is facilitated for New Zealand high-growth companies. | 2012 | snowballeffect.co.nz | Auckland, New Zealand |
Investor details for Veriphi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Veriphi
7 people are tracked at Veriphi (2 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Gregory Joseph Shanahan | Co-Founder & MD | Leadership |
Greg Shanahan | Managing Director | Leadership |
Miriam A. | International Business Development Manger | Team |
Natalee Taylor | In-house Patent Attorney | Team |
Richard Mangnall | Engineering Manager | Team |
Meagan Rootman | Office Manager | Team |
Wei Guo | Senior Software Engineer | Team |
Complete people profiles for Veriphi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Veriphi
3 dated milestones of Veriphi across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Veriphi is founded.
- Funding First funding round of $496K.
- Funding Latest funding round, Grant, of $372K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Veriphi
Veriphi was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Veriphi is headquartered in Auckland, New Zealand.
Veriphi is a funded company, having raised a total of $736.71K across 3 funding rounds to date. The company's 1st funding round was a Seed of $495.71K, raised on May 2016.
Veriphi was founded in 2015 in Auckland, New Zealand, within the health technology sector. Laser-based analyzers and IV consumables are produced to verify drug identity and concentration, reducing errors in hospital intravenous administration. Proof-of-concept trials were completed by October 2017, with commercial versions now under development for hospital trials involving 15 oncology drugs at Auckland Hospital Pharmacy.
Veriphi offers Veriphi Flushing Analyser.
Veriphi has 2 investors. Key investors include Callaghan Innovation, and Snowball Effect.
Veriphi operates through Veriphi Limited.